Skip to content
Search

Latest Stories

Manish Gohel: ‘I had to fight to be part of my son’s life’

Manish Gohel: ‘I had to fight to be part of my son’s life’
"I was judged and blamed for a situation that was developed by two people", says Manish Gohel
Getty Images

THE challenges for Asian women getting married and adjusting their ways for the in-laws are well known, and so are the perceptions of a divorced mother in the Asian community. But what about the Asian father who has been divorced?

Well, as an Asian father, I can say first hand that it was expected for me to walk away from my son. The concerning part was not just from the community around me, or ways in which the law was handled, but also how some family members advised me to give up and walk away, as I had little hope of remaining connected to my son.


I had to fight to be a part of my son’s life. It was a painful journey for me, both financially and mentally, going in and out of courts to ensure I was part of his life. I even had to educate the schools on what parental responsibility was. I was judged and blamed for a situation that was developed by two people.

It was a long struggle of around six years to get equal care arrangements in place, which were mutually agreed with a mediator, as opposed to the family getting involved and emotions sizzling over. While making my way through the various obstacles, I had to also endure the pain of grieving the loss of both my parents to cancer.

Your Voice Manish Gohel Image 1 Manish Gohel

Often, I hear about how hard it is for a mother to raise a child on their own, and yet hardly hear about how challenging it is for the father to stay involved to share the responsibilities.

If a single father is mentioned in a conversation, somehow the focus changes to what happened to the mother? It seems like nothing much has really changed, and fathers are not seen as meaningful or required parents.

As a father, getting support was challenging, especially when the upbringing of an Asian male was to hide emotions and reaching for help was seen as a sign of weakness.

From what I went through, I learnt to ignore the associated stigmas. I used counselling and personal development to gain the tools required to raise my self-esteem and stay focused to reach the desired outcomes. And here I am, a single father, still living and breathing, but now being a meaningful part of my son’s life as his dad and primary provider.

This is just a glimpse of what was in my journey; there were plenty more challenges, and it’s not been shared as a competition of who has it worse, but more for awareness that there are stigmas associated to any parent, whether mother or father.

Manish Gohel is a master NLP practitioner, licensed NLP trainer, and certified Marshall Goldsmith executive coach, incorporating reiki and yoga in his work with clients. He enables individuals or groups to set themselves free from preconceived  ideas, and generational beliefs, to what they can create and want in their lives. Visit www.manishgohel.com for more.

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less